Docking and other computing tools in drug design against SARS-CoV-2
- PMID: 38353209
- DOI: 10.1080/1062936X.2024.2306336
Docking and other computing tools in drug design against SARS-CoV-2
Abstract
The use of computer simulation methods has become an indispensable component in identifying drugs against the SARS-CoV-2 coronavirus. There is a huge body of literature on application of molecular modelling to predict inhibitors against target proteins of SARS-CoV-2. To keep our review clear and readable, we limited ourselves primarily to works that use computational methods to find inhibitors and test the predicted compounds experimentally either in target protein assays or in cell culture with live SARS-CoV-2. Some works containing results of experimental discovery of corresponding inhibitors without using computer modelling are included as examples of a success. Also, some computational works without experimental confirmations are also included if they attract our attention either by simulation methods or by databases used. This review collects studies that use various molecular modelling methods: docking, molecular dynamics, quantum mechanics, machine learning, and others. Most of these studies are based on docking, and other methods are used mainly for post-processing to select the best compounds among those found through docking. Simulation methods are presented concisely, information is also provided on databases of organic compounds that can be useful for virtual screening, and the review itself is structured in accordance with coronavirus target proteins.
Keywords: Docking; SARS-CoV-2; drug design; inhibitors; supercomputing; target proteins.
Similar articles
-
Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.Bioorg Med Chem. 2021 Oct 1;47:116393. doi: 10.1016/j.bmc.2021.116393. Epub 2021 Sep 4. Bioorg Med Chem. 2021. PMID: 34509862 Free PMC article.
-
Identifying SARS-CoV-2 main protease inhibitors by applying the computer screening of a large database of molecules.SAR QSAR Environ Res. 2022 May;33(5):341-356. doi: 10.1080/1062936X.2022.2050424. Epub 2022 May 3. SAR QSAR Environ Res. 2022. PMID: 35502579
-
In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease.Chem Pharm Bull (Tokyo). 2023;71(12):897-905. doi: 10.1248/cpb.c23-00622. Chem Pharm Bull (Tokyo). 2023. PMID: 38044142
-
Docking Paradigm in Drug Design.Curr Top Med Chem. 2021;21(6):507-546. doi: 10.2174/1568026620666201207095626. Curr Top Med Chem. 2021. PMID: 33292135 Review.
-
Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition.Med Res Rev. 2022 Mar;42(2):744-769. doi: 10.1002/med.21862. Epub 2021 Oct 26. Med Res Rev. 2022. PMID: 34697818 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous